A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability

Neomi Van Duijvenbode*, Joanne E.L. Vandernagel

*Corresponding author for this work

    Research output: Contribution to journalReview articleAcademicpeer-review

    2 Citations (Scopus)
    22 Downloads (Pure)

    Abstract

    Although the attention for substance use (SU) and SU disorders (SUD) among individuals with mild to borderline intellectual disability (MBID) has been growing exponentially, this form of dual diagnosis has largely been ignored by addiction medicine. In this article, we systematically review the research between January 2000 and June 2018 on the prevalence, assessment, and treatment of SU(D) among children, adolescents, and adults with MBID. A total of 138 articles were included. It is concluded that individuals with MBID are likely to be at a higher risk for developing SUD compared to those without MBID. Future research should focus on the detection of MBID among patients being treated in addiction medicine, the development and implementation of systematic assessment methods of SU(D) among individuals with MBID, and the development and evaluation of prevention and treatment interventions. System integration, interdisciplinary collaboration, and the development of tailored treatment for individuals with MBID are advised to improve treatment access and outcome for those who have developed SUD.

    Original languageEnglish
    JournalEuropean Addiction Research
    DOIs
    Publication statusE-pub ahead of print/First online - 22 Jul 2019

    Fingerprint

    Intellectual Disability
    Substance-Related Disorders
    disability
    addiction
    Medicine
    Disability Evaluation
    medicine
    Dual (Psychiatry) Diagnosis
    Systems Integration
    Therapeutics
    adolescent
    evaluation
    Research

    Cite this

    @article{6e52809d0b4b46fc941588805c5918e5,
    title = "A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability",
    abstract = "Although the attention for substance use (SU) and SU disorders (SUD) among individuals with mild to borderline intellectual disability (MBID) has been growing exponentially, this form of dual diagnosis has largely been ignored by addiction medicine. In this article, we systematically review the research between January 2000 and June 2018 on the prevalence, assessment, and treatment of SU(D) among children, adolescents, and adults with MBID. A total of 138 articles were included. It is concluded that individuals with MBID are likely to be at a higher risk for developing SUD compared to those without MBID. Future research should focus on the detection of MBID among patients being treated in addiction medicine, the development and implementation of systematic assessment methods of SU(D) among individuals with MBID, and the development and evaluation of prevention and treatment interventions. System integration, interdisciplinary collaboration, and the development of tailored treatment for individuals with MBID are advised to improve treatment access and outcome for those who have developed SUD.",
    author = "{Van Duijvenbode}, Neomi and Vandernagel, {Joanne E.L.}",
    year = "2019",
    month = "7",
    day = "22",
    doi = "10.1159/000501679",
    language = "English",
    journal = "European Addiction Research",
    issn = "1022-6877",
    publisher = "Karger",

    }

    A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. / Van Duijvenbode, Neomi; Vandernagel, Joanne E.L.

    In: European Addiction Research, 22.07.2019.

    Research output: Contribution to journalReview articleAcademicpeer-review

    TY - JOUR

    T1 - A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability

    AU - Van Duijvenbode, Neomi

    AU - Vandernagel, Joanne E.L.

    PY - 2019/7/22

    Y1 - 2019/7/22

    N2 - Although the attention for substance use (SU) and SU disorders (SUD) among individuals with mild to borderline intellectual disability (MBID) has been growing exponentially, this form of dual diagnosis has largely been ignored by addiction medicine. In this article, we systematically review the research between January 2000 and June 2018 on the prevalence, assessment, and treatment of SU(D) among children, adolescents, and adults with MBID. A total of 138 articles were included. It is concluded that individuals with MBID are likely to be at a higher risk for developing SUD compared to those without MBID. Future research should focus on the detection of MBID among patients being treated in addiction medicine, the development and implementation of systematic assessment methods of SU(D) among individuals with MBID, and the development and evaluation of prevention and treatment interventions. System integration, interdisciplinary collaboration, and the development of tailored treatment for individuals with MBID are advised to improve treatment access and outcome for those who have developed SUD.

    AB - Although the attention for substance use (SU) and SU disorders (SUD) among individuals with mild to borderline intellectual disability (MBID) has been growing exponentially, this form of dual diagnosis has largely been ignored by addiction medicine. In this article, we systematically review the research between January 2000 and June 2018 on the prevalence, assessment, and treatment of SU(D) among children, adolescents, and adults with MBID. A total of 138 articles were included. It is concluded that individuals with MBID are likely to be at a higher risk for developing SUD compared to those without MBID. Future research should focus on the detection of MBID among patients being treated in addiction medicine, the development and implementation of systematic assessment methods of SU(D) among individuals with MBID, and the development and evaluation of prevention and treatment interventions. System integration, interdisciplinary collaboration, and the development of tailored treatment for individuals with MBID are advised to improve treatment access and outcome for those who have developed SUD.

    U2 - 10.1159/000501679

    DO - 10.1159/000501679

    M3 - Review article

    AN - SCOPUS:85069628157

    JO - European Addiction Research

    JF - European Addiction Research

    SN - 1022-6877

    ER -